Certification: On third-party certification, the site doesn't say. Where it ships: The site doesn't say which states it serves. Last checked: June 2026, against Eve's own pages. Published price: Eve publishes a figure for semaglutide and tirzepatide — the qualifiers are in "What does Eve cost?" below. What it sells: Brand-name medication as well as compounded, injectable and oral routes. Licensing & trust: 79/100 on the scored dimension of that name — one of the six in our published methodology. Checks out on the facts we can verify: a flat month-to-month price and a dated check against the company's own pages, within the states listed above.

C55/100

Desk Score

Ranked #427

Eve

Q: What does Eve cost?

Semaglutide: $195/mo (compounded). That is a flat month-to-month rate: $195 a month, with no plan term attached to the figure. Median semaglutide figure across this site: $190 a month, of 164 providers with a published month-to-month price and a check date. Eve's $195 a month sits $5 above it. Tirzepatide: $195/mo (compounded). That is a flat month-to-month rate: $195 a month, with no plan term attached to the figure. Median tirzepatide figure across this site: $264 a month, of 163 providers with a published month-to-month price and a check date. Eve's $195 a month sits $69 below it. All figures as published on Eve's own site and read in June 2026. Prices change — confirm before you order.

Eve is a women's-health-focused GLP-1 telehealth platform — distinctive positioning in a largely gender-neutral market.

Desk Score 55/100 (C) · Verified June 2026

Visit Eve ↗Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we write about a provider reads the same either way.

Is Eve legit?

Only what Eve publishes and what we could check ourselves — nothing inferred. See the methodology.

Certification: On third-party certification, the site doesn't say.
Where it ships: The site doesn't say which states it serves.
Last checked: June 2026, against Eve's own pages.
Published price: Eve publishes a figure for semaglutide and tirzepatide — the qualifiers are in "What does Eve cost?" below.
What it sells: Brand-name medication as well as compounded, injectable and oral routes.
Licensing & trust: 79/100 on the scored dimension of that name — one of the six in our published methodology.

Checks out on the facts we can verify: a flat month-to-month price and a dated check against the company's own pages, within the states listed above.

What does Eve cost?

Each figure exactly as Eve publishes it, with the condition attached to it spelled out.

Semaglutide

$195/mo (compounded)

That is a flat month-to-month rate: $195 a month, with no plan term attached to the figure.

Median semaglutide figure across this site: $190 a month, of 164 providers with a published month-to-month price and a check date. Eve's $195 a month sits $5 above it.

Tirzepatide

$195/mo (compounded)

That is a flat month-to-month rate: $195 a month, with no plan term attached to the figure.

Median tirzepatide figure across this site: $264 a month, of 163 providers with a published month-to-month price and a check date. Eve's $195 a month sits $69 below it.

All figures as published on Eve's own site and read in June 2026. Prices change — confirm before you order.

Semaglutide: $195/mo
Tirzepatide: $195/mo
Coverage: Not listed on Eve's site (checked June 2026)
Brand-name: Yes
Verification: Prices as published on Eve's site — verified june 2026. Each figure's full condition is in “What does Eve cost?” below.

Weigh Eve against the full ranked field on the best semaglutide providers ranking, or line it up against its closest alternatives. Or go one-on-one: Eve vs CoreAge Rx.

Desk Score breakdown

Each of the six scored dimensions. See the methodology.

Price transparency30/100

State access24/100

Molecule range90/100

Onboarding speed70/100

Support responsiveness71/100

Licensing & trust79/100

What we like

Genuinely women's-health-focused — fills a real gap among gender-neutral GLP-1 competitors
Both compounded and brand-name FDA-approved options (Wegovy/Ozempic/Mounjaro) on one platform — rare
Publishes the FDA compounded-medication disclaimer
Oral sublingual semaglutide offered alongside injectable

Where points come off

Full states-served list not disclosed publicly
503A pharmacy partner not named, and 503A vs 503B status not specified
Named medical director / clinical leadership not disclosed
Corporate legal entity not disclosed
Governing law / arbitration venue not stated

The bottom line — C

Best for: Women's-health GLP-1 with compounded or brand-name access.

Eve ranks #427 of 542 providers scored — see #1, CoreAge Rx here.

Visit Eve ↗

Pricing and verification reflect Eve's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on Eve's site. Not medical advice; see our disclosure.

← Back to the ranking